Please note that this was recorded in 2017. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.
AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.
Description:
Prior infection with a virus or bacteria can set the stage for development of malignancy. In these presentations the links between two viruses, human papilloma virus (HPV) and Epstein Barr virus (EBV), and the development of cancer are explored. The role of molecular testing in the diagnosis and monitoring of disease are discussed.
HPV and Head and Neck Cancer
Joseph A. Califano, MD, University of California, San Diego, CA, USA
Blood-based Assessment of EBV DNA as a Tumor Marker
Jennifer A. Kanakry, MD, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Learning Objectives:
- Review the epidemiology of viral infections and the development of malignancy.
- Discuss the risks and available treatment for HPV and EBV related cancers.
- Explore the types of testing and their role in the diagnosis and monitoring of affected patients.
Duration: 1.50 hr
Recording Date: November 16, 2017
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
